# BENDAMUSTINE HYDROCHLORIDE

NDC: 83831-183
Generic name: bendamustine hydrochloride
Labeler / Manufacturer: Avyxa Pharma, LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: INJECTION
Routes: INTRAVENOUS
Marketing started: 20260529

FDA application: NDA219014

## Active ingredients

- BENDAMUSTINE HYDROCHLORIDE: 100 mg/4mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"83831-183"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=83831-183
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f359e7c6-d104-457d-a7fe-597c74440353